These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 4254199

  • 1. In vitro studies on the inhibitory effect of lymph-node cells. I. Antitumor activity of regional lymph-node cells from methylcholanthrene-induced sarcoma bearing mice on the same primary culture sarcoma cells.
    Osugi M.
    Acta Med Okayama (1952); 1970 Aug; 24(4):447-56. PubMed ID: 4254199
    [No Abstract] [Full Text] [Related]

  • 2. Inhibitory effect of isologous regional lymphnode cells from the methylcholanthrene-induced sarcoma bearing mice on the tumor in vivo.
    Kashihara E.
    Acta Med Okayama (1952); 1970 Apr; 24(2):161-73. PubMed ID: 4247892
    [No Abstract] [Full Text] [Related]

  • 3. Studies on transplantation immunity of methylcholanthrene-induced tumor by use of transplantation in lymph nodes and of diffusion chamber.
    Kitano M, Okada Y, Nagaishi C.
    Exp Med Surg; 1969 Apr; 27(4):357-83. PubMed ID: 5384538
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of cell-mediated cytotoxicity against tumor-associated antigens by suppressor lymph node cells from mice bearing methylcholanthrene-induced sarcomas.
    Indrová M, Bubeník J.
    Neoplasma; 1979 Apr; 26(4):405-12. PubMed ID: 160510
    [Abstract] [Full Text] [Related]

  • 5. Time-lapse changes in the concomitant immunity of lymphocytes from different sites of mice isografted with methylcholanthrene-induced tumor.
    Orita K, Ohnishi N, Matuso Y, Konaga E, Kokumai Y.
    Acta Med Okayama; 1975 Apr; 29(2):85-91. PubMed ID: 126005
    [Abstract] [Full Text] [Related]

  • 6. In vitro immunization against tumour-associated antigen of methylcholanthrene-induced sarcoma.
    Indrová M, Bubeník J.
    Folia Biol (Praha); 1978 Apr; 24(2):118-27. PubMed ID: 658547
    [Abstract] [Full Text] [Related]

  • 7. Immunogenicity of methylcholanthrene-induced tumors tested by draining lymph node assay in syngeneic rats.
    Ryzewska AG, Rybicka M, Kania A, Dabrowski M.
    Neoplasma; 1980 Apr; 27(5):533-42. PubMed ID: 7231610
    [Abstract] [Full Text] [Related]

  • 8. [Concentration of theta-plus-lymphocytes in the regional and distant lymph nodes C3H/Sn strain mice during development of primary methylcholanthrene sarcomas].
    Iudin VM, Fedorovskaia MI, Umanskiĭ IuA.
    Biull Eksp Biol Med; 1975 Jan; 79(1):57-9. PubMed ID: 1078631
    [No Abstract] [Full Text] [Related]

  • 9. The effect of isogenic lymphoid cell on primary sarcomas in the rat.
    Blamey RW.
    Cancer Res; 1969 Feb; 29(2):333-4. PubMed ID: 4885387
    [No Abstract] [Full Text] [Related]

  • 10. [Mouse rosette forming cells in transplantation immunity].
    Brondz BD, Eliseeva LS, Kotomina IF, Egorova SG.
    Tsitologiia; 1974 Jan; 16(1):74-81. PubMed ID: 4142816
    [No Abstract] [Full Text] [Related]

  • 11. Effect of regional lymphadenectomy on development of concomitant immunity.
    Soloway MS, Pendergrast WJ, Myers GH.
    Surg Forum; 1972 Jan; 23(0):101-2. PubMed ID: 4671039
    [No Abstract] [Full Text] [Related]

  • 12. Macrophage migration inhibition-activity after implantation of methylcholanthrene-induced sarcoma, Ehrlich ascites cancer or mouse ascites hepatoma-134 cancer cells in mice.
    Yumura M.
    Acta Med Okayama; 1976 Feb; 30(1):37-48. PubMed ID: 184687
    [Abstract] [Full Text] [Related]

  • 13. Histological modifications of the lymph nodes in mice bearing syngeneic grafts of tumours induced by methylcholanthrene.
    Simar LJ, Focan C, Boniver J, Betz EH.
    Pathol Eur; 1975 Feb; 10(4):317-25. PubMed ID: 1208123
    [Abstract] [Full Text] [Related]

  • 14. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA, Prehn RT.
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract] [Full Text] [Related]

  • 15. Allogeneic inhibitory activity of regional lymph node cells in the mouse isografted with methylcholanthrene-induced tumor.
    Orita K, Onishi N, Kunisada K, Konaga E, Kokumai Y.
    Acta Med Okayama; 1975 Jun; 29(3):183-7. PubMed ID: 127512
    [Abstract] [Full Text] [Related]

  • 16. Cell-mediated cytotoxicity of adherent and non-adherent mouse lymph node cells sensitized in vitro against tumour-associated antigens of syngenetic methylcholanthrene-induced sarcomas.
    Indrová M, Bubeník J.
    Folia Biol (Praha); 1979 Jun; 25(2):137-41. PubMed ID: 456694
    [Abstract] [Full Text] [Related]

  • 17. [Antitumor activity of the serum and lymphocytes of C57BL mice in chemical carcinogenesis].
    Umanskiĭ IuA, Kushko LIa, Semenova-Kobzar' RA.
    Vopr Onkol; 1980 Jun; 26(2):42-6. PubMed ID: 7361493
    [Abstract] [Full Text] [Related]

  • 18. Immunological activity of regional lymph nodes in tumor-bearing mice.
    Barna BP, Deodhar SD.
    Cancer Res; 1979 Jul; 39(7 Pt 1):2711-7. PubMed ID: 312691
    [Abstract] [Full Text] [Related]

  • 19. Establishment and immunologic characterization of 3-methylcholanthrene-induced sarcoma cell lines metastasizing widely in mice and exhibiting distinct and selective propensities for the mode of metastasis.
    Kodama Y, Seyama T, Kamiya K, Yokoro K.
    J Natl Cancer Inst; 1982 Sep; 69(3):595-605. PubMed ID: 7050499
    [Abstract] [Full Text] [Related]

  • 20. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L, Hunter N, Mason K, Withers HR.
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.